NCT01544140View on ClinicalTrials.gov

Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Midazolam

Oral syrup 7.5 mg, single dose

DRUG

vandetanib

Oral tablets, 800 mg, single dose

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY